The Global Veterinary Pharmaceuticals Market Report by The Business Research Company covers veterinary pharmaceuticals market drivers and restraints, veterinary pharmaceuticals market size, major players, and the impact of COVID-19 on the veterinary pharmaceuticals market.
The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals and related services. This industry includes establishments that produce veterinary medicines which are used for pet animals and farm animals (includes vaccines, antibiotics and parasiticides).
The global veterinary pharmaceuticals market is expected to decline from $14.8 billion in 2019 to $13.1 billion in 2020 at a compound annual growth rate (CAGR) of -11.6%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the animal sector. The restrictions on non-essential medical services coupled with slowed production of veterinary pharmaceuticals due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 7.5% from 2021 and reach $19.7 billion in 2023.
Request A Sample For The Global Veterinary Pharmaceuticals Market Report:
Some veterinary pharmaceuticals market trends include the rise in generic drugs for animal care. The economical nature of generic drugs is enabling the pet lovers to take care of their pets efficiently.
Global veterinary pharmaceuticals market segments include:
1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Others.
2) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug stores.
3) By Route Of Administration: Oral, Others (Parental, Topical).
4) By Animal Type: Companion Animals, Livestock Animals.
5) By Vaccines: Inactivated vaccines, Attenuated vaccines, Recombinant vaccines.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest global veterinary pharmaceuticals market share.
Read More On The Veterinary Pharmaceuticals Global Market Report 2021: COVID-19 Impact and Recovery to 2030 At:
The Veterinary Pharmaceuticals Market – By Animal Type (Livestock, Companion Animal), By Type Of Pharmaceutical (Veterinary Parasiticides, Veterinary Vaccines, Veterinary Antibiotics, Others), By Administration Route (Oral, Others), By End Use, And By Region, Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals market overviews, analyzes and forecasts market size, share, veterinary pharmaceuticals market players, veterinary pharmaceuticals market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The veterinary pharmaceuticals identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Veterinary Pharmaceuticals Market – Opportunities And Strategies – Global Forecast To 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Merck & Co. Inc, Zoetis Inc., Eli Lilly and Company, Bayer AG, Boehringer Ingelheim GmbH, Perrigo Company plc, Virbac SA, Dechra Pharmaceuticals plc, Ceva Sante Animale, Aratana Therapeutics, Inc., Vetoquinol, Ceva Santé Animale, Virbac SA, Pegasus Laboratories, Inc, Provetica AH LLC, Norbrook Laboratories, Ltd, Putney, Inc., Elanco US Inc, Phibro Animal Health Corp., Bimeda Animal Health Ltd., Syndel USA.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Veterinary Pharmaceuticals Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Veterinary Pharmaceuticals Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Veterinary Pharmaceuticals Global Market Report 2021: